Hepatic CYP2E1 induction has also been found in many studies performed in different rodent models of obesity and NAFLD [49,57,82,86–91], although there are some exceptions as mentioned in Section 4.2.2. Here, CYP2E1 is linked to metabolic dysfunction-associated steatotic liver disease.